Clinical Trials Logo

Clinical Trial Summary

Corticomedullary differentiation (CMD) abnormality (absent/reversed) is a parameter that can indicate possible nephropathy. The evolution of CMD across gestation had not been well established. Devrendt et al demonstrated the presence of CMD in all fetuses older then 20 weeks. In our study we would like to determine the exact timing of it's sonographic visualisation. This is a prospective study recruiting women between 14-24 week gestation during routine ultrasound screening. A midsagittal image of each kidney will be taken by a single sonographer and examined for the presence of the CMD by two other sonographers blinded to gestational age.


Clinical Trial Description

n/a


Study Design

Observational Model: Case-Only, Time Perspective: Cross-Sectional


Related Conditions & MeSH terms


NCT number NCT02193516
Study type Observational
Source Meir Medical Center
Contact Efrat Hadi, MD
Phone 09-7472871
Status Not yet recruiting
Phase N/A
Start date July 2014
Completion date June 2015

See also
  Status Clinical Trial Phase
Enrolling by invitation NCT05530356 - Renal Hemodynamics, Energetics and Insulin Resistance: A Follow-up Study
Recruiting NCT01448889 - Normobaric Hyperoxygenation for Prevention of Contrast Induced Nephropathy N/A
Active, not recruiting NCT05026021 - Prediction of BKvirus Nephropathy Risk by the NEPHROVIR Method in Kidney Transplant Patients With BKvirus Viremia
Completed NCT02470247 - Interest of Remote Ischemic Preconditioning for Prevention of Contrast Medium-induced Nephropathy in High Risk Patients N/A
Recruiting NCT05511779 - Study to Confirm of the Safety and Tolerability of Brincidofovir in Subjects With BK Virus Infection (Viremia) After Kidney Transplantation Phase 2
Active, not recruiting NCT03620773 - Impact of Metabolic Surgery on Pancreatic, Renal and Cardiovascular Health in Youth With Type 2 Diabetes Phase 1/Phase 2
Active, not recruiting NCT03584217 - Renal HEIR Study: Renal Hemodynamics, Energetics and Insulin Resistance in Youth Onset Type 2 Diabetes Study Phase 1/Phase 2
Completed NCT03618420 - Copeptin in Adolescent Participants With Type 1 Diabetes and Early Renal Hemodynamic Function Phase 1/Phase 2
Completed NCT02575092 - The Relationship Between HHcy and Contrast-induced Nephropathy in Hypertensive Patients After Coronary Artery Diagnosis and Treatment Phase 2/Phase 3
Recruiting NCT05839314 - Effect of Huaier Granule on the Treatment of Idiopathic Membranous Nephropathy Phase 4
Completed NCT01638663 - Effect of the Aquaretic Tolvaptan on Nitric Oxide System (TORA) Phase 2
Completed NCT01213498 - The Effects of Atorvastatin on the Nitric Oxide-system in Patients With Non-diabetic Nephropathy Phase 2
Completed NCT01208701 - The Effects of Atorvastatin on the Nitrogen Oxide-system in Patients With Type 2 Diabetes and Nephropathy Phase 2
Completed NCT01214746 - The Effects of Atorvastatin on the Nitric Oxide-system in Healthy Young Man Phase 2
Active, not recruiting NCT00655330 - Probucol Combined With Valsartan in Reducing Proteinuria in Diabetes Nephropathy N/A
Completed NCT00308347 - A Research Study to Evaluate the Renal (Kidney) Protective Effects of Losartan in Patients With Non-insulin Dependent Diabetes (0954-147)(COMPLETED) Phase 3
Terminated NCT00579995 - A Prospective, Randomized TrialComparing Oral N-Acetylcysteine and Intravenous Sodium Bicarbonate N/A
Completed NCT05986474 - Development of Synthetic Medical Data Generation Technology to Predict Postoperative Complications
Recruiting NCT03886714 - Screening for Fabry Disease in Renal Transplantation
Recruiting NCT06325059 - The Role of Renal Progenitors and Polyploid Tubular Cell Response in Glomerular and Tubular Diseases N/A